Literature DB >> 19660619

Relation of serum leptin with cardiac mass and left atrial dimension in individuals >70 years of age.

Wolfgang Lieb1, Lisa M Sullivan, Jayashri Aragam, Tamara B Harris, Ronenn Roubenoff, Emelia J Benjamin, Ramachandran S Vasan.   

Abstract

Experimental evidence indicates that leptin-deficient animals develop left ventricular (LV) hypertrophy, but data relating circulating leptin levels to cardiac structure and function in subjects >70 years old are lacking. We related circulating leptin concentrations to echocardiographic measurements of cardiac structure and function in 432 participants of the community-based Framingham Heart Study (mean age 75 years, 67% women) who underwent echocardiography at a routine examination (approximately 4 years before leptin concentrations were assayed). In multivariable linear regression, logarithmically transformed gender-standardized leptin concentrations were related to the following echocardiographic measurements: LV mass, left atrial size, and fractional shortening (primary analysis); LV wall thickness and LV end-diastolic dimensions (the 2 components of LV mass); and transmitral early/late diastolic filling velocities (secondary analysis). Leptin concentrations were inversely associated with LV mass, LV wall thickness, and left atrial size (p <0.04 for all). The top gender-specific tertile of leptin was associated with an adjusted LV mass 16 g lower compared with the lowest tertile (p = 0.007 for trend across tertiles). Leptin levels were not associated with LV fractional shortening, transmitral early/late diastolic filling velocities, or LV end-diastolic diameter (p >0.16). In conclusion, our cross-sectional observations suggest a cardioprotective influence of leptin on LV remodeling consistent with experimental data and may provide insight into the potential role of leptin resistance as a mediator of obesity-associated cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19660619      PMCID: PMC2745631          DOI: 10.1016/j.amjcard.2009.04.026

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  23 in total

1.  An appraisal of echocardiography as an epidemiological tool. The Strong Heart Study.

Authors:  Richard B Devereux; Mary J Roman; Jennifer E Liu; Elisa T Lee; Wenyu Wang; Richard R Fabsitz; Thomas K Welty; Barbara V Howard
Journal:  Ann Epidemiol       Date:  2003-04       Impact factor: 3.797

2.  Leptin does not induce hypertrophy, cell cycle alterations, or production of MCP-1 in cultured rat and mouse cardiomyocytes.

Authors:  Roberto Piñieiro; María J Iglesias; Sonia Eiras; Juan Viñuela; Francisca Lago; José R González-Juanatey
Journal:  Endocr Res       Date:  2005       Impact factor: 1.720

3.  Independent association of plasma leptin levels and left ventricular isovolumic relaxation in uncomplicated hypertension.

Authors:  M Galderisi; M R Tagliamonte; A D'Errico; C Carella; G Varricchio; S Mondillo; O de Divitiis; G Paolisso
Journal:  Am J Hypertens       Date:  2001-10       Impact factor: 2.689

Review 4.  Central nervous system control of food intake and body weight.

Authors:  G J Morton; D E Cummings; D G Baskin; G S Barsh; M W Schwartz
Journal:  Nature       Date:  2006-09-21       Impact factor: 49.962

5.  Plasma leptin level is associated with myocardial wall thickness in hypertensive insulin-resistant men.

Authors:  G Paolisso; M R Tagliamonte; M Galderisi; G A Zito; A Petrocelli; C Carella; O de Divitiis; M Varricchio
Journal:  Hypertension       Date:  1999-11       Impact factor: 10.190

6.  Leptin attenuates cardiac contraction in rat ventricular myocytes. Role of NO.

Authors:  M W Nickola; L E Wold; P B Colligan; G J Wang; W K Samson; J Ren
Journal:  Hypertension       Date:  2000-10       Impact factor: 10.190

7.  Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample.

Authors:  M Fischer; A Baessler; H W Hense; C Hengstenberg; M Muscholl; S Holmer; A Döring; U Broeckel; G Riegger; H Schunkert
Journal:  Eur Heart J       Date:  2003-02       Impact factor: 29.983

8.  Leptin resistance is associated with extreme obesity and aggregates in families.

Authors:  J H Lee; D R Reed; R A Price
Journal:  Int J Obes Relat Metab Disord       Date:  2001-10

9.  Obesity and the risk of heart failure.

Authors:  Satish Kenchaiah; Jane C Evans; Daniel Levy; Peter W F Wilson; Emelia J Benjamin; Martin G Larson; William B Kannel; Ramachandran S Vasan
Journal:  N Engl J Med       Date:  2002-08-01       Impact factor: 91.245

10.  Elevated serum levels of leptin and soluble leptin receptor in patients with advanced chronic heart failure.

Authors:  P Christian Schulze; Juergen Kratzsch; Axel Linke; Nina Schoene; Volker Adams; Stephan Gielen; Sandra Erbs; Sven Moebius-Winkler; Gerhard Schuler
Journal:  Eur J Heart Fail       Date:  2003-01       Impact factor: 15.534

View more
  16 in total

1.  Association of serum leptin with future left ventricular structure and function: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Shishir Sharma; Laura A Colangelo; Matthew A Allison; Joao A C Lima; Bharath Ambale-Venkatesh; Satoru Kishi; Kiang Liu; Philip Greenland
Journal:  Int J Cardiol       Date:  2015-05-14       Impact factor: 4.164

2.  Obesity and right ventricular structure and function: the MESA-Right Ventricle Study.

Authors:  Harjit Chahal; Robyn L McClelland; Harikrishna Tandri; Aditya Jain; Evrim B Turkbey; W Gregory Hundley; R Graham Barr; Jorge Kizer; João A C Lima; David A Bluemke; Steven M Kawut
Journal:  Chest       Date:  2011-08-25       Impact factor: 9.410

3.  The role of leptin in the ventricular remodeling process and its mechanism.

Authors:  Guoxing Zuo; Xinping Du; Liuying Zheng; Cuancuan Wang; Kuan Wang; Ying Li
Journal:  Int J Clin Exp Med       Date:  2015-04-15

4.  Leptin and incident cardiovascular disease: the Multi-ethnic Study of Atherosclerosis (MESA).

Authors:  Seth S Martin; Michael J Blaha; Evan D Muse; Atif N Qasim; Muredach P Reilly; Roger S Blumenthal; Khurram Nasir; Michael H Criqui; Robyn L McClelland; Jan M Hughes-Austin; Matthew A Allison
Journal:  Atherosclerosis       Date:  2014-12-20       Impact factor: 5.162

Review 5.  Adipose tissue biology and cardiomyopathy: translational implications.

Authors:  Aslan T Turer; Joseph A Hill; Joel K Elmquist; Philipp E Scherer
Journal:  Circ Res       Date:  2012-12-07       Impact factor: 17.367

6.  Higher plasma leptin levels are associated with reduced left ventricular mass and left ventricular diastolic stiffness in black women: insights from the Genetic Epidemiology Network of Arteriopathy (GENOA) study.

Authors:  Daisuke Kamimura; Takeki Suzuki; Wanmei Wang; Matthew deShazo; John E Hall; Michael D Winniford; Iftikhar J Kullo; Thomas H Mosley; Kenneth R Butler; Michael E Hall
Journal:  Hypertens Res       Date:  2018-06-15       Impact factor: 3.872

7.  Correlation between advanced glycation end-products and the expression of fatty inflammatory factors in type II diabetic cardiomyopathy.

Authors:  Zhengdong Guo; Donghui Huang; Xiange Tang; Jingjing Han; Jing Li
Journal:  Bosn J Basic Med Sci       Date:  2015-10-25       Impact factor: 3.363

8.  Relation of leptin to left ventricular hypertrophy (from the Multi-Ethnic Study of Atherosclerosis).

Authors:  Matthew A Allison; David A Bluemke; Robyn McClelland; Mary Cushman; Michael H Criqui; Joseph F Polak; Joao A Lima
Journal:  Am J Cardiol       Date:  2013-05-24       Impact factor: 2.778

Review 9.  Heart Failure in Women--Insights from the Framingham Heart Study.

Authors:  Satish Kenchaiah; Ramachandran S Vasan
Journal:  Cardiovasc Drugs Ther       Date:  2015-08       Impact factor: 3.727

10.  Leptin, leptin gene and leptin receptor gene polymorphism in heart failure with preserved ejection fraction.

Authors:  Tarek A Abd El-Aziz; Randa H Mohamed; Rasha H Mohamed; Heba F Pasha
Journal:  Heart Vessels       Date:  2011-05-17       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.